18 April, 03:17
For Sale - Zoll MSeries CCT Defibrillator - New
New and used medical equipment listings are published daily at MedGlobalGroup.com!🌎https://loom.ly/VRK1fRY #medicalequipment #medicaldevices #biomedical #medicaldevicesales
New and used medical equipment listings are published daily at MedGlobalGroup.com!🌎https://loom.ly/VRK1fRY #medicalequipment #medicaldevices #biomedical #medicaldevicesales
Zoll MSeries CCT Defibrillator | MedGlobal Group
Defibrillator with accessories
https://loom.ly/VRK1fRY
28 November, 06:52
✨ Stopping the spread of MRSAs, VREs, and other infectious microbes can save hospitals millions of dollars as well as improving patient outcomes. Harloff's isolation carts and door mount/wall mount isolation cabinets are designed to store all the supplies required by protocol to reduce the risk of pathogen transmission in hospitals between patients, healthcare workers and visitors. ⭐🌎🌎❗❗
Call: ☎️ +1 844-990-0460
Email:✉️ infoimedical.solutions
Product URL:- https://bit.ly/3in1tCA
Visit For More Similar Products URL:- https://bit.ly/3V9f1jo
#hospitalbed #patientroom #hospitalfurniture #hospitalbedrental #norfolk #imedical #hospitalbed #Healthcare #medicalequipment #medicaldevices #hospital #health #doctor #medicalsupply #pharmacy #nurse #medicine #stretchers #ritterchairs #foldingstretchers #rehabproducts #medicalsupplier #usa #medicalprofessional #meddevice #medicaldevicesales #medicalmedium #wellness #medicalcare
Call: ☎️ +1 844-990-0460
Email:✉️ infoimedical.solutions
Product URL:- https://bit.ly/3in1tCA
Visit For More Similar Products URL:- https://bit.ly/3V9f1jo
#hospitalbed #patientroom #hospitalfurniture #hospitalbedrental #norfolk #imedical #hospitalbed #Healthcare #medicalequipment #medicaldevices #hospital #health #doctor #medicalsupply #pharmacy #nurse #medicine #stretchers #ritterchairs #foldingstretchers #rehabproducts #medicalsupplier #usa #medicalprofessional #meddevice #medicaldevicesales #medicalmedium #wellness #medicalcare
20 October, 03:19
#Phispers Week 41 - Weekly Pharma News Recap
Bonjour,
- FDA publishes GDUFA III user fees, increases ANDA, DMF fees.
- Merck’s cardiovascular disease drug succeeds in late-stage trial, validates US$ 11.5 bn Acceleron buyout.
- FDA grants fast-track status to Lilly’s diabetes drug Mounjaro to treat obesity.
- Bayer’s Vividion signs potential US$ 930 million oncology deal with Tavros.
- GSK’s Boostrix vaccine gets add-on approval to prevent whooping cough in infants.
- Sanofi, Regeneron flaunt Dupixent’s benefit in eosinophilic esophagitis trial in kids.
- Two-year data on Roche’s Evrysdi shows benefit in spinal muscular atrophy.
- US ADHD drug crisis deepens as Novartis’ Sandoz also reports shortage of Adderall.
- EDQM finds one major deficiency at Biocon’s API facility in Bengaluru.
#Phispers This Week - PharmaCompass.com's Weekly News Recap
#Healthcare #pharmaceuticals #pharmanews #pharmaceuticalindustry
https://lnkd.in/dE5X4qag
Bonjour,
- FDA publishes GDUFA III user fees, increases ANDA, DMF fees.
- Merck’s cardiovascular disease drug succeeds in late-stage trial, validates US$ 11.5 bn Acceleron buyout.
- FDA grants fast-track status to Lilly’s diabetes drug Mounjaro to treat obesity.
- Bayer’s Vividion signs potential US$ 930 million oncology deal with Tavros.
- GSK’s Boostrix vaccine gets add-on approval to prevent whooping cough in infants.
- Sanofi, Regeneron flaunt Dupixent’s benefit in eosinophilic esophagitis trial in kids.
- Two-year data on Roche’s Evrysdi shows benefit in spinal muscular atrophy.
- US ADHD drug crisis deepens as Novartis’ Sandoz also reports shortage of Adderall.
- EDQM finds one major deficiency at Biocon’s API facility in Bengaluru.
#Phispers This Week - PharmaCompass.com's Weekly News Recap
#Healthcare #pharmaceuticals #pharmanews #pharmaceuticalindustry
https://lnkd.in/dE5X4qag
FDA steps up user fee under GDUFA III; Merck’s heart drug succeeds in late-stage study | Radio Compass Phisper
On September 30, the US President Joe Biden had signed into law the Food and Drug Administration Reauthorization Act (FDARA), which includes the reauthorization of the Generic Drug User Fee Amendments (GDUFA) through September 2027. In this week’s Phispers, we bring you the new GDUFA III fe...
https://lnkd.in/dE5X4qag
23 September, 03:09
The big day has finally come. LOGYTalks is starting the paid feature!
The paid feature in LOGYTalks will give you a chance, as a speaker, to promote yourself and share your knowledge with a global community, while getting PAID for it.
LOGYTalks allows you to take 80% of earnings, giving you multiple payment gateways with a full secured process.
Need to know more? Contact us NOW 👉 membershiplogytalks.com
#LOGYTalks #Eventplatform #events #paidversion #summit #Webinar #online #onlineevents #new #launch #newfeature #agriculture #leadership #environment #finance #vr #ar #blockchain
The paid feature in LOGYTalks will give you a chance, as a speaker, to promote yourself and share your knowledge with a global community, while getting PAID for it.
LOGYTalks allows you to take 80% of earnings, giving you multiple payment gateways with a full secured process.
Need to know more? Contact us NOW 👉 membershiplogytalks.com
#LOGYTalks #Eventplatform #events #paidversion #summit #Webinar #online #onlineevents #new #launch #newfeature #agriculture #leadership #environment #finance #vr #ar #blockchain
